When innovation meets purpose, change follows.
We’re proud to announce that ReVentas has been awarded funding from Innovate UK to take on one of the Sustainable Medicines Manufacturing Innovation Programme’s Grand Challenges — developing fully circular pharmaceutical packaging through the Suspack project
Suspack brings together a powerful consortium of partners across the value chain. Led by the National Physics Laboratory the consortium features Impact Recycling, Nextek, and ReVentas, with support from the UK’s Sustainable Medicines Manufacturing Innovation Programme (SMMIP). Together, we’re working to transform the way pharmaceutical packaging is made, used, and reused — starting with the packaging waste generated by the NHS .
Today, most pharmaceutical packaging, from blister packs to medicine bottles, follows a one-way route: production, use, disposal. Even where recycling exists, contamination and mixed materials make true circularity nearly impossible with almost all NHS waste currently incinerated.
Suspack aims to change that.
Closing the loop on healthcare packaging
The project will establish a complete circular process for pharmaceutical plastics. Waste packaging from NHS supply chains will first be mechanically recycled by Impact Recycling, then purified using advanced solvent-based technologies developed by ReVentas and supercritical CO2 solutions developed by Nextek. This dual approach removes contaminants and additives while preserving the polymer itself — producing high-purity recycled resin suitable for reuse in regulated pharmaceutical applications.
It’s a first for the sector: circularity without compromise. A pathway where healthcare plastics can meet the same quality and safety standards as virgin material, while drastically reducing carbon impact and waste.
At ReVentas, we believe that purity is the key to circularity. Using our selective dissolution process, we’ll purify recovered polymer to virgin-like quality — restoring colour, clarity and performance without breaking polymer chains. By keeping the material whole, the Suspack model shows how physical recycling can deliver both sustainability and product integrity, even in demanding environments like healthcare.
Partnership with purpose
Innovate UK describes the Sustainable Medicines Manufacturing Innovation Programme as a platform for “industry-led innovation that strengthens the UK’s medicines ecosystem while reducing waste, emissions and energy use”
Suspack embodies that mission — bringing together expertise from across industry to make sustainable medicine packaging not just possible, but practical.
As we begin this project, we’re not just looking at how packaging is recycled — we’re re-imagining how it’s designed, manufactured, and valued. It’s another step in proving that circularity can be simple when purity is built in from the start.
ReVentas is proud to help lead this transformation. To learn more about our work on Suspack and the future of circular pharmaceutical packaging, get in touch with our team.
